Remedus Pharma SRL

Remedus Pharma reported total assets of €3.33m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).

By total assets for 2025, Remedus Pharma ranks among the 5,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0480.727.149 · VAT BE0480727149
1861 Meise
active in Business and other management consultancy activities (NACE 70200)
operating since 05 Jun 2003 (≈ 23 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Remedus Pharma shows with a free account.

See the score
Profile
SRL since 2003
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−327,197 €
Equity−380,911 €
Cash15,443 €
EBITDA−103,665 €
Total assets€3.33m
Solvency-11.4%
The line marks its sector median: 58.4% (26338 companies).

Change 2022 → 2025: Total assets +81 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Remedus Pharma's annual accounts

20252024202320222021
Net result−327,197 €
Equity−380,911 €
Cash15,443 €
EBITDA−103,665 €
Total assets€3.33m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 31 Aug 2026
  • Year ended 31 Dec 2024filed on 30 Aug 2025
  • Year ended 31 Dec 2023filed on 30 Sep 2024
  • Year ended 31 Dec 2022filed on 31 Oct 2023
  • Year ended 31 Dec 2021filed on 04 Jul 2022

Remedus Pharma's financial analysis

Management and control of Remedus Pharma

2 active director(s) in the register.

Remedus Pharma's shareholders and holdings →

Remedus Pharma's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0480.727.149
VAT number
BE0480727149
Peppol
Registered · 0208:0480727149 · as of 10 Nov 2026
Legal form
SRL
Incorporated
05 Jun 2003
Registered office
1861 Meise
Latest accounts
2025 · filed on 31 Aug 2026
Activity
Business and other management consultancy activities (NACE 70200)

Remedus Pharma (SRL) has been based in Meise since 2003, active in: business and other management consultancy activities. For 2025, it reports a net loss of 327,197 € and equity of −380,911 €; its revenue is not published. Its solvency stands at -11.4%, below the median of its sector (58.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Remedus Pharma

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Remedus Pharma

What is the revenue of Remedus Pharma?

Remedus Pharma files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Remedus Pharma?

In Belgium, the VAT number is the company number prefixed with BE: BE0480727149 for Remedus Pharma, if the company is VAT-registered. Its company number (CBE) is 0480.727.149.

Where is the registered office of Remedus Pharma?

According to the CBE register, the registered office of Remedus Pharma is in 1861 Meise.

What is the equity of Remedus Pharma?

At the close of the 2025 financial year, the equity of Remedus Pharma amounts to -380,911 €, a solvency of -11.4% of total assets.

Who manages Remedus Pharma?

The register lists 2 active mandates at Remedus Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Remedus Pharma within its sector?

By total assets for 2025, Remedus Pharma ranks among the 5,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.

Idonis

The full file of Remedus Pharma

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 14 Sep 2026

No credit card, no commitment.

What each plan unlocks →